Etiological profile and antimicrobial sensitivity in community urinary infections in a Private Center in the city of Córdoba
Keywords:
Urinary Tract Infections, Microbial Sensitivity Tests, Community-Acquired InfectionsAbstract
ABSTRACT
Introduction: Urinary Tract Infection is still one of the most frequent infectious entities in our institution; however its incidence has changed over the last decade. The objective of this study is to determine which are the microorganisms responsible for urinary infection in the community and what is the prevalence of antimicrobial resistance of said uropathogens, in order to establish the appropriate empiric treatment in our institution. Materials and methods: Descriptive, retrospective, cross-sectional study of outpatients with a first episode of UTI registered at Sanatorio Allende in the city of Córdoba, Argentina from January 2016 to December 2017. There were 1740 analyzed urine cultures which met the inclusion criteria. The 90,2% (n=1570) of the analyzed total are female. Escherichia coli was the most frequently isolated microorganism (80,3%), followed by Staphylococcus saprophyticus (8,0%), Klebsiella pneumoniae (4,1%), Enterococcus faecalis (3%), Proteus mirabilis (2,3%), and others (2,1%). Out of 1740 isolations, 47,6% were resistant to ampicillin, 29,6% to sulfamethoxazole trimethoprim, 15,2% to ciprofloxacin, 4,6% to first-generation cephalosporins, 3,4% to cefixime, 2,3% to amoxicillin clavulanic, 1,2% to Gentamicin and 1% to Nitrofurantoin. Conclusion: This study shows higher prevalence of Escherichia coli with high rates of resistance to ampicillin, treatments and fluoroquinolones. Thus, it is important to identify and characterize the microorganisms and sensitivity profiles to antimicrobials in order to be able to define critically which much be the top-of-the-line antibiotics chosen for an empiric treatment.
Downloads
References
Referencias
1. Alós J.I. Epidemiología y etiología de la infección urinaria comunitaria. Sensibilidad antimicrobiana de los principales patógenos y significado clínico de la resistencia. Enferm Infecc Microbiol Clin 2005;23(4):3-8
2. Medina-Polo J, Guerrero-Ramos F, Pérez-Cadavid S, Arrebola-Pajares A, Sopeña-Sutil R, Benitez-Sala R, Jimenez-Alcaide E, García-González L, Alonso-Isa M, Lara-Isla A, Passas-Martínez J.B, Tejido-Sanchez A. Infecciones urinarias adquiridas en la comunidad que requieren hospitalización: factores de riesgo características microbiológicas y resistencia a antibióticos. Actas Urol Esp. 2015; 39(2):104-111
3. Prieto L, Esteban M, Salinas J, Adot J.M, Arlandis S, Peri L, Cozar J.M. Consensus document of the Spanish Urological Association on the management of uncomplicated recurrent urinary tract infections. Actas Urol Esp. 2015; 39(6): 339-348
4. Andreu A, Cacho J, Coira A, Lepe J.A. Diagnóstico microbiológico de las infecciones del tracto urinario. Enferm Infecc Microbiol Clin. 2011; 29(1):52-57
5. Pigrau-Serrallach C. Infecciones urinarias recurrentes. Enferm Infecc Microbiol Clin 2005; 23 Supl 1:28-39
6. Rodriguez-Baño, Navarro M.D. Extended-spectrum b-lactamases in ambulatory care: a clinical perspective. Clin Microbiol Infect 2008; 14(1):104-110
7. Jean SS, Coombs G, Ling T, Balajj V, Rodrigues C, Mikamo H, Kim MJ, Rajaserkaram DG, Mendoza M, Tan TY, Kiratisin P, Ni Y, Weinman B, Xu Y, Hsueh PR. Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013. Int J Antimicrob Agents. 2016 Apr; 47(4):328-34.
8. Grabe M, Bartoletti R, Bjerklun Johansen T.E, Cai T, Cek M, KÖves B, Naber K.G, Pickard R.S, Tenke P, Wagenlehner F, Wullt B. Guidelines on Urological infections. European Association of Urology 2015.
9. Hickerson AD, Carson CC. The treatment of urinary tract infections and use of ciprofloxacin extended release. Expert Opin Investig Drugs. 2006;15(5):519-32.
10. Ochoa Sangrador C, Eiros Bouza J.M, Pérez Méndez C, Ingliada Galiada L. The etiology of urinary tract infections and the antimicrobial susceptibility of urinary pathogens. Rev Esp Quimioterap. 2005;18(2):124-135
11. Passadouro R, Fonseca R, Figueiredo F, Lopes A, Fernandes C. Evaluation of the Antimicrobial Susceptibility of Community-Acquired Urinary Tract Infection. Acta Med Port 2014;27(6):737-742
12. Cordova E, Lespada MI, Cecchini D, Jacob N, Gomez N, Gutfraind G, Badía M, Rodriguez Ismael C. Prevalencia de gérmenes multirresistentes en infecciones del tracto urinario de la comunidad y asociadas a los cuidados de la salud. Actualizaciones en sida e infectología. 2014;22(84):33-38
13. Wong CKM, Kung K, Au-Doung PLW, Ip M, Lee N, Fung A,Shan Wong SY. Antibiotic resistance rates and physician antibiotic prescription patterns of uncomplicated urinary tract infections in southern Chinese primary care. PLoS ONE 2017;12(5): e0177266
14. Andreu A, Alós JI, Gobernado M, Marco F, De la Rosa M, García-Rodríguez JA. Etiología y sensibilidad a los antimicrobianos de los uropatógenos causantes de la infección urinaria baja adquirida en la comunidad. Enferm Infecc Microbiol Clin 2005;23(1):4-9
15. Andreu Domingo A, Cacho J, Coira Nieto A, Lepe Jiménez JA. Diagnóstico microbiológico de las infecciones del tracto urinario. Procedimientos en microbiología clínica, 2°Edición 2010, 14ª p.1-42
16. Clinical and Laboratory Standars Institute. Performance Standards for Antimicrobial Susceptibility Testing; 29th ed CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute, 2019
17. Bertoni G, Pessacq P, Guerrini MG, Calmaggi A, Barberis F, Jorge L, Bonvehi P, Temporiti E, Herrera F, Obed M, Alcorta B, Farias J, Mykietiuk A. Etiología y resistencia a antimicrobianos de la infección no complicada del tracto urinario. Medicina (B. Aires) 2017;77:304-308.
18. Lucero Celeste, Tuduri Ezequiel, Pasterán Fernando, Corso Alejandra. Vigilancia de la resistencia a los antimicrobianos en asilamientos de E. coli proveniente de infecciones urinarias de la comunidad en Argentina. VIII Congreso de la Sociedad Argentina de Bacteriología, Micología y Parasitología Clínicas (SADEBAC), 2018, Ciudad Autónoma de Buenos Aires, Argentina
19. García-Tello A, Gimbernat H, Redondo C, Arana DM, Cacho J, Angulo JC. Betalactamasas de espectro extendido en las infecciones del tracto urinario causadas por enterobacterias: aproximación a su conocimiento y pautas de actuación. Actas Urol Esp 2014;38(10):678-684
20. Lopez Furst MJ, Mykietiuk A Pessacq et al. Community-acquired uncomplicated urinary tract infections (UTI): current etiology and antimicrobial susceptibility in Argentina. A prospective, observational, multicenter study. Abstract number: SADI 03.005. International Journal of Infectious Diseases 738 (2018)3-398
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Escuela de Salud Pública y Ambiente. Facultad de Ciencias Médicas. Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License which allows the work to be copied, distributed, exhibited and interpreted as long as it is not done for commercial purposes.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication process. (See The Effect of Open Access). (See The Effect of Open Access).
